Whitehawk Therapeutics Inc
NASDAQ:WHWKBiotechnology
+$0.06 today
- Market cap
- $184.11M
- Beta
- 0.77
- P/E (TTM)
- -2.6
- EPS (TTM)
- -$1.67
Volume 0.40M
Average 0.31M
Returns on capital
Whitehawk Therapeutics Inc management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-15.1%
avg -22.2%
ROIC
-83.9%
avg 247.7%
ROA
-13.7%
avg -49.8%
Analysis
ROA is currently the strongest return metric at -13.7% versus its period average of -49.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
David J. Lennon | President, Chief Executive Officer & Director | USD 1.07M | 55 | — | — |
Scott Giacobello | Chief Financial Officer, Treasurer, Investor Relations & Corporate Communications | USD 721.56K | 56 | — | — |
Bryan Ball | Chief Technical Operations Officer | USD 687.46K | 56 | 91.63K | 0.19% |
Neil Desai | Founder & Director | USD 40K | 61 | 38.04K | 0.08% |
David Dornan | Chief Scientific Officer | — | 48 | 85.89K | 0.17% |
Margaret Han Dugan | Chief Medical Officer | — | 69 | — | — |
Stephen Rodin | Senior Vice President of Legal & General Counsel | — | 50 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 15, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
14
$2.58M
Net Transaction Value
−$2.58M
Net selling
Most Active
Lennon David James
6 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Apr 16, 26Apr 16, 2026 | Giacobello Scott M. Direct | Sell | $584.8K$584,808.00 |
| Apr 15, 26Apr 15, 2026 | Giacobello Scott M. Direct | Sell | $297.2K$297,220.00 |
| Apr 14, 26Apr 14, 2026 | BALL BRYAN Direct | Sell | $336.6K$336,554.40 |
| Apr 13, 26Apr 13, 2026 | BALL BRYAN Direct | Sell | $91.3K$91,305.94 |
| Apr 10, 26Apr 10, 2026 | BALL BRYAN Direct | Sell | $22.6K$22,624.28 |
| Apr 9, 26Apr 9, 2026 | BALL BRYAN Direct | Sell | $178.5K$178,500.00 |
| Apr 9, 26Apr 9, 2026 | Lennon David James Direct | Sell | $49K$49,010.00 |
| Apr 8, 26Apr 8, 2026 | Lennon David James Direct | Sell | $217.4K$217,413.00 |
| Apr 7, 26Apr 7, 2026 | Lennon David James Direct | Sell | $322.7K$322,718.41 |
| Apr 6, 26Apr 6, 2026 | Lennon David James Direct | Sell | $359.4K$359,406.45 |
1–10 of 14
Summary
Insiders reported 0 buys worth $0.00 and 14 sells worth $2.58M over the last 12 months. That adds up to net selling of $2.58M. Lennon David James was the most active insider with 6 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A4 analysts |
| Revenue | N/A | N/A | -22.3% | +36.1% (5yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | N/A | N/A6 analysts |
Analysis
Recent growth has been strongest in Revenue at -22.3% over three years. Forward estimates point to Revenue at +36.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Whitehawk Therapeutics Inc compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about WHWK's management, answered from reported figures.
Who manages WHWK?
Whitehawk Therapeutics Inc (WHWK) lists 7 active executives. The top listed executive is Bryan Ball, Chief Technical Operations Officer.
Are WHWK insiders buying or selling?
Recent insider activity shows net buying of $22.06M.
Continue the stock analysis
Jump to another research area for this company.